Method For Treating Cognitve Disorders Read more about Method For Treating Cognitve Disorders US Application 60/367,068Filed on 2002-03-22
Method And Structures For Microengineering Neocartilage Scaffolds Read more about Method And Structures For Microengineering Neocartilage Scaffolds US Application 60/286,852Filed on 2001-04-27
Long-acting insulinotropic peptides and uses thereof Read more about Long-acting insulinotropic peptides and uses thereof US Application 60/309,076Filed on 2001-07-31
GIP (1-30) GLUd3 as a Treatment for Type II Diabetes Read more about GIP (1-30) GLUd3 as a Treatment for Type II Diabetes US Application 60/471,368Filed on 2003-05-15
Tetrahydrobenzothiazole Analogues as Neuroprotective Agents Read more about Tetrahydrobenzothiazole Analogues as Neuroprotective Agents US Application 60/216,388Filed on 2000-07-06
Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof Read more about Agents Useful For Reducing Amyloid Precursor Protein And Treating Dementia And Methods of Use Thereof US Application 60/245,329Filed on 2000-11-02
Tumor Markers in Ovarian Cancer Read more about Tumor Markers in Ovarian Cancer US Application 60/194,336Filed on 2000-04-03
ESTABLISHMENT OF CELLULAR MANIPULATIONS WHICH ENCHANCE OLIGO MEDIATED GENE TARGETING. Read more about ESTABLISHMENT OF CELLULAR MANIPULATIONS WHICH ENCHANCE OLIGO MEDIATED GENE TARGETING. US Application 60/191,996Filed on 2000-03-24
Method and Apparatus for Coating an Endoprosthesis Read more about Method and Apparatus for Coating an Endoprosthesis US Application 60/176,989Filed on 2000-01-19
Angiogenic/Vasculogenic Property of a Plasmid-Liposome Vector not Encoded for a Specific Growth Factor. Read more about Angiogenic/Vasculogenic Property of a Plasmid-Liposome Vector not Encoded for a Specific Growth Factor. US Application 60/119,487Filed on 1999-02-10